Pharmacological Characterization of FR194921, a New Potent, Selective, and Orally Active Antagonist for Central Adenosine A1 Receptors-Reference-Cited by-同舟云学术

Pharmacological Characterization of FR194921, a New Potent, Selective, and Orally Active Antagonist for Central Adenosine A1 Receptors

Published:2004 Issue:1 Volume:96 Page:42-52
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:J Pharmacol Sci

Author:

Maemoto Takuya,Tada Miho,Mihara Takuma,Ueyama Noriko,Matsuoka Hideaki,Harada Katsuya,Yamaji Takayuki,Shirakawa Kiyoharu,Kuroda Satoru,Akahane Atsushi,Iwashita Akinori,Matsuoka Nobuya,Mutoh Seitaro

Publisher

Japanese Pharmacological Society

Subject

Pharmacology,Molecular Medicine

Reference43 articles.

1. Adenosine receptors

2. ATP- and Adenosine-Mediated Signaling in the Central Nervous System: Adenosine Receptor Activation by ATP Through Rapid and Localized Generation of Adenosine by Ecto-nucleotidases

3. The distribution of adenosine a1 receptors and 5'-nucleotidase in the brain of some commonly used experimental animals

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in the Development of Pyrimidine-based CNS Agents;Current Drug Discovery Technologies;2023-03

2. Comparative Study of Receptor-, Receptor State-, and Membrane-Dependent Cholesterol Binding Sites in A_2A and A₁ Adenosine Receptors Using Coarse-Grained Molecular Dynamics Simulations;Journal of Chemical Information and Modeling;2023-01-13

3. Dual A1/A3 Adenosine Receptor Antagonists: Binding Kinetics and Structure−Activity Relationship Studies Using Mutagenesis and Alchemical Binding Free Energy Calculations;Journal of Medicinal Chemistry;2022-09-29

4. Comparative Study of State-Dependent Cholesterol Binding Sites in Adenosine A_2A and A₁ Receptors Using Coarse-Grained Molecular Dynamics Simulations in Biologically Relevant Membranes;2022-09-28

5. Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A₁ Antagonists;Journal of Medicinal Chemistry;2022-01-22